Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
36,87 USD | -2,46% | -0,35% | +71,33% |
15/05 | Spyre Therapeutics, Inc. Kondigt wijzigingen in de Raad van Bestuur aan | CI |
13/05 | SPYRE THERAPEUTICS, INC. : Wells Fargo Securities herhaalt koopadvies | ZM |
Omzet 2024 * | 5,84 mln. 5,38 mln. | Omzet 2025 * | 4,43 mln. 4,08 mln. | Marktkapitalisatie | 1,52 mld. 1,4 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -174 mln. -160 mln. | Nettowinst (verlies) 2025 * | -193 mln. -178 mln. | EV/omzet 2024 * | 151 x |
Nettoliquiditeiten 2024 * | 638 mln. 587 mln. | Nettoliquiditeiten 2025 * | 333 mln. 307 mln. | EV/omzet 2025 * | 269 x |
K/w-verhouding 2024 * |
-9,03
x | K/w-verhouding 2025 * |
-10,6
x | Werknemers | 30 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 88,69% |
Recentste transcriptie over Spyre Therapeutics, Inc.
1 dag | -2,46% | ||
1 week | -0,35% | ||
Lopende maand | +11,63% | ||
1 maand | +10,74% | ||
3 maanden | +67,97% | ||
6 maanden | +251,14% | ||
Lopend jaar | +71,33% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Cameron Turtle
CEO | Chief Executive Officer | 34 | 22-06-23 |
Scott Burrows
DFI | Director of Finance/CFO | 47 | 01-09-23 |
Brian Connolly
CTO | Chief Tech/Sci/R&D Officer | - | 27/11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Tomas Kiselak
BRD | Director/Board Member | 38 | 22-06-23 |
Jeffrey Albers
BRD | Director/Board Member | 52 | 27/11 |
Peter Harwin
BRD | Director/Board Member | 38 | 22-06-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
20-05-24 | 36,87 | -2,46% | 240 623 |
17-05-24 | 37,8 | 0,00% | 308 277 |
16-05-24 | 37,8 | +1,12% | 282 967 |
15-05-24 | 37,38 | -4,86% | 299 261 |
14-05-24 | 39,29 | +6,19% | 400 122 |
uitgestelde koers Nasdaq, 20 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+71,33% | 1,52 mld. | |
+9,58% | 115 mld. | |
+12,41% | 106 mld. | |
-2,59% | 21,96 mld. | |
-12,38% | 21,87 mld. | |
-5,29% | 19,21 mld. | |
-3,35% | 18,08 mld. | |
-38,57% | 17,71 mld. | |
+7,51% | 14,32 mld. | |
+35,67% | 12,42 mld. |